"My account reflect the tremendous gains". Of course, what better time to sell 10,000 shares than in the premarket. :-)) Whatever makes you feel better about yourself, I'm all for it. :-)) So you will invest in gfy next? :-))
Of course if you were truthful at all, when challenged about owning the stock, a credible person would have said they sold in the pm at $225 because you would have known what premarket prices were. But, as your posts show, you had no idea what premarket prices were. Instead you had to "digg" for an answer to defend your lie. Second, don't just look at what the pre market high is. Look at how many trades are around the price point you want others to believe you sold at (4shares, 88 shares, 37 shares, 29 shares, 100 shares, 25 shares, 15 shares, 22 shares, etc) and do the math as to how many add up to 10,000 shares that you want others to believe you owned.. It doesn't add up. You make things up. AS never would.
Until you and Sg learn to stop lying and embellishing, you will be challenged as to the truth of your posts. Keep it up and continue to ruin the credibility of yourselves and this mb.
Below you just posted this, that you sold at $225. When did it hit $225, not recently right? So why did you say above "Now that's the way to start my day" as if you STILL owned this stock. Is your post below another lie?
stockgal25 • 4 minutes 11 seconds ago Flag
0users liked this postsusers disliked this posts2Reply
bought n sold icpt several times since july lol Dec 3rd buy til sold $225
See below for how you mislead others into thinking you've made out big on this stock, now proven untrue. That's similar to the stock that you pretended to own because it doubled the day before when the truth was it was a reverse stock split. IF you truly owned it you would have known that but you just saw it on top of the daily gainers list and chose to post it. This was your joke of a defense after we told you of the reverse split:
Reply to portly by stockgal25 •Dec 17, 2014 10:01 AM
stockgal25 • Dec 17, 2014 10:55 AM
0users liked this postsusers disliked this posts4Reply
It was a split...1-2 whats the problem. No gain thats what they wanted.
Ha ha. That's why specifics from your posts are so important. When you bought the stock in mid July it was over $200 per share. Now it's $198 per share after yesterday's $20+ dollar increase. What are you bragging about? :-))
I think they are cutting staff or should be anyway. Usually cuts are in sales positions that are unnecessary because of plans to partner. Just one example, look at the executive list on their website. I could swear that there was a VP of sales or director of sales at one time......some position with "sales" in the title. Scott Shively was mainly responsible for Zohydro. When he left, he wasn't replaced. RH took over his responsibilities. Maybe the corporate development guy is handling sales. I don't know. But the point is I believe they are streamlining whether to prepare for partnership or, as you say, cut overhead.
I'll make a gentleman's bet. No bad news because the product will be approved. It's an sNDA not an NDA, the molecule with ER is already approved and the ADT is basic. In other words, there is nothing new here for the FDA to be concerned about. Then there will be a "relief" rally after the announcement from those who were worried. Then it all depends on management and their ability to communicate and execute their strategy for significantly increasing sales of Zohydro ADFand how quickly that will contribute to positive earnings.
Impressive, another mention of a stock symbol (GENE) at the top of the daily top gainers list. Impressive run. :-)) In regards to ICPT, I for one don't recall you mentioning it. Love to see a copy of your post recommending it to others. Thanks for contributing. :-))
The true entrepreneurial spirit is to be able to confront issues head on. Instead, out of fear of admitting a lie, you erased the posts about your made up trip to visit RH and your fake "private deal" with him. Have the guts to admit the truth and get some credibility back. And what man says "poor baby"?
I should have mentioned the description of Battelle is a copy and paste from the list of Exhibitors during the upcoming DDP conference.
Dosepro will be represented in Battelle's exhibit. No specific DosePro presentations on the agenda though. Will be interesting to see who from Zogenix will be working at the Battelle exhibit.